Antiretroviral treatment in 1999: from uncertainty to hopefulness
Pujol de la Llave, E.
Anales de Medicina Interna 16(5): 215-217
1999
ISSN/ISBN: 0212-7199 PMID: 10389304 Document Number: 511160
Document emailed within 1 workday
Related Documents
Payzan-LeNestour, E.; Bossaerts, P. 2011: Risk, unexpected uncertainty, and estimation uncertainty: Bayesian learning in unstable settings Plos Computational Biology 7(1): E1001048Kang, Y. 2009: Role of health locus of control between uncertainty and uncertainty appraisal among patients with atrial fibrillation Western Journal of Nursing Research 31(2): 187-200
Tuboi, S.H.; Brinkhof, M.W.G.; Egger, M.; Stone, R.A.; Braitstein, P.; Nash, D.; Sprinz, E.; Dabis, Fçois.; Harrison, L.H.; Schechter, M. 2007: Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration Journal of Acquired Immune Deficiency Syndromes 45(1): 52-59
Kouanfack, C.; Montavon, C.; Laurent, C.; Aghokeng, A.; Kenfack, A.; Bourgeois, A.; Koulla-Shiro, S.; Mpoudi-Ngole, E.; Peeters, M.; Delaporte, E. 2009: Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 48(9): 1318-1322
Tuboi, S.H.; Brinkhof, M.W.G.; Egger, M.; Stone, R.A.; Braitstein, P.; Nash, D.; Sprinz, E.; Dabis, Fçois.; Harrison, L.H.; Schechter, M. 2007: Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration Journal of Acquired Immune Deficiency Syndromes 45(1): 52-59
Baesi, K.; Ravanshad, M.; Ghanbarisafari, M.; Saberfar, E.; Seyedalinaghi, S.; Volk, J.E. 2014: Antiretroviral drug resistance among antiretroviral-naïve and treatment experienced patients infected with HIV in Iran Journal of Medical Virology 86(7): 1093-1098
Corzillius, M.; Mühlberger, N.; Sroczynski, G.; Jaeger, H.; Wasem, J.ür.; Siebert, U. 2004: Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV Antiviral Therapy 9(1): 27-36
Lailulo, Y.; Kitenge, M.; Jaffer, S.; Aluko, O.; Nyasulu, P.S. 2020: Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review and metaanalysis Systematic Reviews 9(1): 292
Termaat, J.; Wheatley, E.; Bloom, M.V.; Freeman, J.W.; Huntington, M.K. 2013: Treatment in the face of uncertainty following traumatic anhydrous ammonia exposure Journal of Family Practice 62(12): 710-718
Vergne, L.; Malonga-Mouellet, G.; Mistoul, I.; Mavoungou, R.; Mansaray, H.; Peeters, M.; Delaporte, E. 2002: Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries Journal of Acquired Immune Deficiency Syndromes 29(2): 165-168
Orsi, F.; d'almeida, C. 2010: Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries Current Opinion in HIV and Aids 5(3): 237-241
Orsi, F.; d'almeida, C. 2010: Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries Current Opinion in HIV and Aids 5(3): 237-241
Vergne, L.; Malonga-Mouellet, G.; Mistoul, I.; Mavoungou, R.; Mansaray, H.; Peeters, M.; Delaporte, E. 2002: Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries Journal of Acquired Immune Deficiency Syndromes 29(2): 165-168
Kesler, A.; Feinsod, M. 2004: Indirect traumatic optic neuropathy--problems and challenges in diagnosis and uncertainty in treatment Harefuah 143(5): 359-363; 390
Lelievre, E.; Le Coeur, S. 2012: Intergenerational relationships within families of HIV-infected adults under antiretroviral treatment in Northern Thailand - Relations intergénérationnelles au sein des familles comportant un adulte infecté par le VIH et recevant un traitement antirétroviral en Thaìlande du Nord Ageing and Society 32(4): 561-585
Gifford, F. 2001: Uncertainty about clinical equipoise. Clinical equipoise and the uncertainty principles both require further scrutiny Bmj 322(7289): 795
Muhamadi, L.; Nsabagasani, X.; Tumwesigye, M.Nazarius.; Wabwire-Mangen, F.; Ekström, A-Mia.; Peterson, S.; Pariyo, G. 2010: Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda Health Policy 97(2-3): 187-194
Sampaio, C.; Ferreira, J.; Costa, J. 2000: Numbers needed for treatment and their respective confidence intervals: useful tools to assess clinical significance and uncertainty associated with medical interventions Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 19(12): 1303-1308
Tymejczyk, O.; Hoffman, S.; Kulkarni, S.G.; Gadisa, T.; Lahuerta, M.; Remien, R.H.; Elul, B.; El-Sadr, W.; Melaku, Z.; Nash, D. 2016: HIV Care and Treatment Beliefs among Patients Initiating Antiretroviral Treatment (ART) in Oromia, Ethiopia Aids and Behavior 20(5): 998-1008
Meyer-Rath, G.; Over, M. 2012: HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions Plos Medicine 9(7): E1001247